Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0000899243-22-013713 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-05 | 2022-04-01 | VRTX | Ambrose Kristen | SVP, CAO | F - Tax | $263.09 | -137 | 3,823 | -3% | -$36.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | F | D | 137 | $263.09 | 3,823 | D | — | — |